glycopyrrolate Tablets 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada
Unavailable markets
Peru
Available for
Licensing with supply, Distribution only
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 15 days